Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: A case-control study

International Journal of Cancer

Volumn 122, Issue 10, 2008, Pages 2377-2379

  Patel, Anita S ^a   Karagas, Margaret R ^b   Pawlita, Michael ^c   Waterboer, Tim ^c   Nelson, Heather H ^d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

EVER2; Human papillomavirus; Skin cancer

Indexed keywords

ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; EPIDERMODYSPLASIA VERRUCIFORMIS; EVER1 GENE; EVER2 GENE; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN PAPILLOMAVIRUS 5; HUMAN PAPILLOMAVIRUS 8; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RARE DISEASE; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VERRUCA VULGARIS; VIRUS GENE; WART VIRUS; WILD TYPE; ADULT; AGED; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENETICS; MALE; MIDDLE AGED; PAPILLOMA VIRUS; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN TUMOR; VIROLOGY; VIRUS INFECTION;

MEMBRANE PROTEIN; TMC6 PROTEIN, HUMAN; TMC8 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; SKIN NEOPLASMS;

EID: 42149142853     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23377     Document Type: Article

References (16)

1. Lewaandowsky F, Lutz W. Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch Dermatol Syphilol 1922;14:193-203.
2. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006;18:362-74.
3. Ramoz N, Rueda LA, Bouadjar B, Favre M, Orth G. A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 1999;112:259-63.
4. Ramoz N, Taieb A, Rueda LA, Montoya LS, Bouadjar B, Favre M, Orth G. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 2000;114:1148-53.
5. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002;32:579-81.
6. Tate G, Suzuki T, Kishimoto K, Mitsuya T. Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J Hum Genet 2004;49:223-5.
7. Zuo Y-G, Ma D, Zhang Y, Qiao J, Wang B. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis. J Dermatol Sci 2006;44:153-9.
8. Berthelot C, Dickerson MC, Rady P, He Q, Niroomand F, Tyring SK, Pandya AG. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol 2007;56:882-6.
9. Harwood CA, Proby CM. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002;15:101-14.
10. Pfister H. Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003;31:52-6.
11. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, Green AC, Bavinck JN, Perry A, Spencer S, Rees JR, Mott LA, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006;98:389-95.
12. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999;81:555-9.
13. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 2005;51:1845-53.
14. Sehr P, Zumbach K, Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001;253:153-62.
15. Sehr P, Muller M, Hopfl R, Widschwendter A, Pawlita M. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione -S-transferase. J Virol Methods 2002;106:61-70.
16. Keresztes G, Mutai H, Heller S. TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics 2003;4:24.